Lyndsay N. Harris

机构：National Institutes of Health, National Cancer Institute, National Cancer Institute · ORCID：0000-0002-9774-6719

发表论文 487 篇 · 总被引 25013 次 · h-index 68

代表论文

• Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute’s Vanguard Study (2025 · Cancer Epidemiology Biomarkers & Prevention · 被引 8)
• Digital pathology imaging artificial intelligence in cancer research and clinical trials: An NCI workshop report (2025 · Journal of Pathology Informatics · 被引 7)
• Risk Factors for COVID-19–Related Hospitalization and Death in Patients With Cancer (2025 · JAMA Oncology · 被引 6)
• Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K (2025 · Clinical Cancer Research · 被引 4)
• Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E (2026 · JCO Precision Oncology · 被引 2)
• PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P (2025 · JCO Precision Oncology · 被引 2)